YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Intravenous Aspirin Use in Migraine Attacks

dc.authorscopusid 6701642517
dc.authorscopusid 35564273500
dc.authorscopusid 6505795472
dc.contributor.author Anlar, Ö.
dc.contributor.author Tombul, T.
dc.contributor.author Kisli, M.
dc.date.accessioned 2025-05-10T17:51:06Z
dc.date.available 2025-05-10T17:51:06Z
dc.date.issued 2003
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Anlar Ö., Yuzuncu Yil Universitesi, Tip Fakültesi, Nöroloji Anabilim Dali, Van, Turkey, Yuzuncu Yil Universitesi, Tip Fakültesi Hastanesi, Nöroloji ABD, 65200 Van, Turkey; Tombul T., Yuzuncu Yil Universitesi, Tip Fakültesi, Nöroloji Anabilim Dali, Van, Turkey; Kisli M., Yuzuncu Yil Universitesi, Tip Fakültesi, Nöroloji Anabilim Dali, Van, Turkey en_US
dc.description.abstract Aspirin is an efficient and cheap analgesic drug, which is used frequently. It is given orally in our country up to date. Use of aspirin intravenously in migraine headache has recently been tried and satisfying results were reported. Thirty-five patients with migraine attacks were admitted to emergency service. Twenty-three patients were treated by 900 mg Lysine acetylsalicylate (LASA)-equivalent of 500 mg aspirin intravenously (I.V). Twelve patients were treated by subcutaneous (S.C) injection of 6 mg sumatriptan. In the patients treated with LASA, the headache relieved clearly in 15 (62.5%) within 4-15 minutes. A moderate pain relief was obtained in 4 patients (17.4%) and there was slight improvement headache in 3 patients (13.1%). There was no response in one patient (4.3%). The pain was disappeared within 30-120 minutes in ten patients (83%) who were treated by sumatriptan. Sumatriptan was not beneficial in two patients (17%). Because of its rapid action and low cost, LASA I.V can be accepted as an effective therapy in migraine attacks treatment. en_US
dc.identifier.endpage 21 en_US
dc.identifier.issn 1301-1375
dc.identifier.issue 1 en_US
dc.identifier.scopus 2-s2.0-0141960111
dc.identifier.scopusquality N/A
dc.identifier.startpage 19 en_US
dc.identifier.uri https://hdl.handle.net/20.500.14720/17987
dc.identifier.volume 9 en_US
dc.identifier.wosquality N/A
dc.language.iso tr en_US
dc.publisher Turkish Society of Cerebrovascular Diseases en_US
dc.relation.ispartof Turk Beyin Damar Hastaliklar Dergisi en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Aspirin en_US
dc.subject Intravenous Use en_US
dc.subject Lysine-Acetylsalicylate en_US
dc.subject Migraine en_US
dc.subject Sumatriptan en_US
dc.title Intravenous Aspirin Use in Migraine Attacks en_US
dc.type Article en_US

Files